Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Nanotechnology Platform for the Delivery of Docetaxel and Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer Therapy.
Journal: Pharmaceutical nanotechnology
Published: November 22, 2024
Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer.
Journal: Breast cancer research and treatment
Published: August 03, 2022
Fabrication of Paclitaxel and 17AAG-loaded Poly-ε-Caprolactone Nanoparticles for Breast Cancer Treatment.
Journal: Journal of pharmaceutics & drug delivery research
Published: March 08, 2021
Computer Optimization of Stealth Biodegradable Polymeric Dual-loaded Nanoparticles for Cancer Therapy Using Central Composite Face-centered Design.
Journal: Pharmaceutical nanotechnology
Published: December 07, 2019
Showing 1-4 of 4
Last Updated: 09/26/2026